Takeover in Pharma Strides Arcolab Acquires Shasun Pharmaceuticals

Editor: Dominik Stephan

Strides Arcolab has taken over Shasun Pharmaceuticals: The two companies well-complement each other by creating a vertically integrated pharma company of scale with strong presence in Front-ended Regulated Markets, Finished Dosages, Emerging Markets Branded Generics, Institutional Business, Active Pharmaceutical Ingredients and Contract Research and Manufacturing Services.

Related Vendors

(Picture: Ernhofer/PROCESS)

Banglore/India - Commenting on the merger, Founder and Group CEO, Strides Arcolab Ltd, Arun Kumar, stated “Since the divestment of our injectables business, which resulted in significant value creation for our shareholders, Strides has refocused on its oral finished formulation business. Today’s proposed combination with Shasun accelerates our strategy and growth prospects by creating a larger scale, fully integrated, leading Indian pharma company with multiple growth drivers and synergies that will allow for enhanced profitability and more efficient use of our combined infrastructure and enhanced value creation opportunities for the combined shareholder group. I am excited to work more closely with the Shasun promoters and leadership in jointly building the combined entity to become one of the leading global players.”